TipRanks
Incyte Corp (DE:ICY)
XETRA:ICY
Germany Market
ICY
Incyte
RESEARCH TOOLSreports

Incyte (ICY) Stock News & Sentiment

4 Followers
Incyte: KRAS G12D PDAC Data Underscore Undervalued Opportunity as Buy Rating and $152 Price Target Are Reiterated
Premium
Ratings
Incyte: KRAS G12D PDAC Data Underscore Undervalued Opportunity as Buy Rating and $152 Price Target Are Reiterated
5d ago
INCY
INCY Upcoming Earnings Report: What to Expect?
Premium
Pre-Earnings
INCY Upcoming Earnings Report: What to Expect?
5d ago
INCY
Balanced View on Incyte: Promising Oncology Pipeline Offset by Long-Term Execution and Timing Risks Justifying Hold Rating
Premium
Ratings
Balanced View on Incyte: Promising Oncology Pipeline Offset by Long-Term Execution and Timing Risks Justifying Hold Rating
5d ago
INCY
Incyte Buy Rating Reiterated as KRAS G12D Asset Shows Differentiated Efficacy; $152 Price Target Maintained
Premium
Ratings
Incyte Buy Rating Reiterated as KRAS G12D Asset Shows Differentiated Efficacy; $152 Price Target Maintained
19d ago
INCY
Incyte’s Latest Dermal PK Study: What Completed Early-Stage Data Mean for INCY Investors
Premium
Company Announcements
Incyte’s Latest Dermal PK Study: What Completed Early-Stage Data Mean for INCY Investors
23d ago
INCY
Incyte’s KRAS G12D Lead Supports Undervalued Upside as Kapoor Reiterates Buy and Maintains $152 Price Target
Premium
Ratings
Incyte’s KRAS G12D Lead Supports Undervalued Upside as Kapoor Reiterates Buy and Maintains $152 Price Target
1M ago
INCY
Incyte: Atebrioz Approval and KRAS Pipeline Upside Drive Buy Rating; Price Target Raised to $152
Premium
Ratings
Incyte: Atebrioz Approval and KRAS Pipeline Upside Drive Buy Rating; Price Target Raised to $152
1M ago
INCY
More DE:ICY News >

ICY News on the Web

S&P 500 Gap Movers for October 30, 2026
Chartmill
Bullish
Incyte price target lowered to $127 from $128 at Wells Fargo
TipRanks News
Neutral
Wells Fargo Remains a Hold on Incyte (INCY)
TipRanks News
Neutral
Incyte price target raised to $143 from $139 at Barclays
TipRanks News
Bullish
Oppenheimer upgrades Incyte on growth outside of Jakafi
TipRanks News
Bullish
INCY Upcoming Earnings Report: What to Expect?
TipRanks News
Bullish
Analysts Offer Insights on Healthcare Companies: Perspective Therapeutics (CATX), Incyte (INCY) and BioNTech SE (BNTX)
TipRanks News
Neutral
Incyte, Genmab announce clinical trial collaboration to evaluate INCB161734
TipRanks News
Bullish

News Score - Last 7 Days

Very Positive
DE:ICY
Sector Average
Media Buzz
This Week36 articles
Weekly Average10 articles
News Sentiment
This Week100%
Sector Average91%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is DE:ICY’s Media Buzz Sentiment?
36 articles about DE:ICY were published this week. In an average week, 10 articles are published.
    What is DE:ICY’s weekly average amount of articles?
    In an average week, 10 articles about DE:ICY are published.
      What is DE:ICY’s News Sentiment?
      100% of articles about DE:ICY were positive this week, compared to its sector average of 91%.
        Healthcare Stocks that are Trending in the News
        GKOSGlaukos
        CNCCentene
        ASNDAscendis Pharma
        GILDGilead Sciences
        MRKMerck & Company
        Showing the stocks with the most bullish news sentiment over the past week